Fourrts has a wide range of Oral Anti-Diabetic (OAD) and Diabetes adjuvant therapy drugs.
Fourrts is the pioneer in introducing Metfil VG a triple combination of Metformin + Glimipride + Voglibose.
Fourrts has an exclusive range of drugs to manage Diabetic Complications like Diabetic Nephropathy, Diabetic Neuropathy, Diabetic Dry Foot and Diabetes induced Erectile dysfunction.
Diabetes is a major public health concern in India, with over 77 million people living with diabetes, with nearly 1 in 2 cases going undiagnosed. Uncontrolled blood sugar can silently lead to serious complications, impacting the eyes (retinopathy), kidneys (nephropathy), nerves (neuropathy), and heart. In fact, diabetes doubles the risk of cardiovascular disease and contributes to 75% of related deaths.
Early diagnosis, lifestyle changes, and timely medical intervention are key to preventing these outcomes. With the rise of digital screening tools and science-backed therapies, diabetes management is more effective today than ever.
Fourrts offers a comprehensive range of solutions in obstetrics & gynecology, supporting women through every stage of maternal and reproductive health. Our portfolio includes trusted products for prenatal care, as well as targeted therapies for conditions like UTI, oligohydramnios, muscle cramps, and mastalgia. As a pioneer in the Indian nutraceutical space, Fourrts has introduced several first-in-class brands such as Argin, Ubicar, KMac, and Prenatal—each formulated with science-backed ingredients to ensure safety, efficacy, and well-being for both mother and baby.